Cancer Therapy-Related Cardiac Dysfunction: An Overview for the Clinician

Clinical Medicine Insights. Cardiology
Irving E PerezRhea Sancassani

Abstract

Cancer therapy-related cardiac dysfunction (CTRCD) is one of the most feared and undesirable side effects of chemotherapy, occurring in approximately 10% of the patients. It can be classified as direct (dose-dependent vs dose-independent) or indirect, either case being potentially permanent or reversible. Risk assessment, recognition, and prevention of CTRCD are crucial.

References

Nov 1, 1979·Annals of Internal Medicine·D D Von HoffF M Muggia
Feb 8, 1979·The New England Journal of Medicine·J AlexanderB L Zaret
Feb 1, 1974·Annals of Internal Medicine·R H Blum, S K Carter
Apr 1, 1974·Annals of Internal Medicine·M E GershwinA D Steinberg
Jan 1, 1993·Annals of Internal Medicine·Z M QuezadoF P Ognibene
Jun 17, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T ColomboM D'Incalci
May 2, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·V B Pai, M C Nahata
Aug 10, 2000·Journal of the American College of Cardiology·D CardinaleC Fiorentini
May 15, 2001·American Journal of Physiology. Cell Physiology·N Ferrara
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew SeidmanDeborah Keefe
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven E LipshultzSteven D Colan
Aug 6, 2003·Acta Oncologica·M Wasif SaifJean L Grem
Oct 13, 2004·Toxicology and Applied Pharmacology·Paulo J OliveiraKendall B Wallace
Jan 12, 2005·European Journal of Heart Failure·Gedske DaugaardAndreas Kjaer
Apr 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael S Ewer, Scott M Lippman
Dec 15, 2005·British Journal of Haematology·Karlijn A WoutersSteven E Lipshultz
Nov 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martee L HensleyLynn M Schuchter
Dec 17, 2009·Journal of the National Cancer Institute·Adriana AlbiniDouglas M Noonan
Feb 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Markhaba TukenovaFlorent de Vathaire
Apr 20, 2010·International Journal of Cardiology·Jean-Jacques MonsuezJean-Yves Artigou
Aug 24, 2010·Progress in Cardiovascular Diseases·Giuseppe CuriglianoAron Goldhirsch
Dec 4, 2010·The Lancet Oncology·Adrian M Jubb, Adrian L Harris
Jan 6, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Toni K ChoueiriFabio A B Schutz
Aug 20, 2011·Journal of the American College of Cardiology·Zeydin AcarMustafa Tarık Ağaç
Oct 14, 2011·The New England Journal of Medicine·Dennis SlamonUNKNOWN Breast Cancer International Research Group
Nov 30, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Javier G BlancoSmita Bhatia
Feb 22, 2012·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Ronny S JijiMichael Salerno
Mar 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven E LipshultzStephen E Sallan
Jun 26, 2012·International Journal of Cardiology·Mehmet G KayaYat Yin Lam
Jul 5, 2012·Current Cardiology Reviews·Maria Volkova, Raymond Russell
Aug 25, 2012·The American Journal of Cardiology·Tomas G NeilanRaymond Y Kwong
Oct 30, 2012·Nature Medicine·Sui ZhangEdward T H Yeh

❮ Previous
Next ❯

Citations

Jul 8, 2020·Cancers·Giuseppe SaltalamacchiaErica Quaquarini
Aug 10, 2020·Current Cardiology Reports·Domenico D'AmarioGianluigi Savarese
Aug 5, 2020·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·K A JonesC A Paterson
Oct 21, 2020·Journal of Thrombosis and Thrombolysis·Abishai DominicJun-Ichi Abe
Feb 5, 2021·Circulation. Heart Failure·Arjun SinhaSadiya S Khan
Dec 6, 2020·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kei KunimasaToru Kumagai
Mar 12, 2021·Biochemical and Biophysical Research Communications·Xiaoli ChengYaling Han
Apr 30, 2021·Colombia médica : CM·Adriana Linares BallesterosIván Perdomo Ramírez
Jun 3, 2021·Journal of Clinical Medicine·Angita JainDeLisa Fairweather
Jun 8, 2021·International Journal of Cardiology. Hypertension·Shannon K ParrCarl J Ade
Jun 23, 2021·Cardio-Oncology·Rudolf A de BoerSherry-Ann Brown
Jul 6, 2021·Anesthesiology and Pain Medicine·Islam Mohammad ShehataOmar Viswanath
Aug 28, 2021·Antioxidants·Priyanka KarekarShubha Gururaja Rao

❮ Previous
Next ❯

Software Mentioned

MUGA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.